Inventor · disambiguated record
Leifeng Cheng
Also filed as: CHENG LEIFENG
7 granted patents·21 pending applications·29 citations·filing 1994–2010
80Inventor score
Top patents by PatentIndex Score
28 records- 0182US7576095B2Therapeutic agentsASTRAZENECA AB·Filed 2007·Granted Aug 18, 2009·7 cites·3 claims
- 0273US7875626B2Therapeutic agentsASTRAZENECA AB·Filed 2006·Granted Jan 25, 2011·2 cites·5 claims
- 0358US5858979AInhibitors and substrates of thrombinTRIGEN LTD·Filed 1995·Granted Jan 12, 1999·13 cites·39 claims
- 0446US2008262026A1Therapeutic Agents 684ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 0544US2008262064A1Novel Compounds For The Treatment Of GI Disorders 682ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 0643US2006135523A12-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulatorASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 0743US2007099923A1Therapeutic agentsCHENG LEIFENG·Filed 2004·Application pending·0 cites
- 0843US2007093484A13-Substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulatorsASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 0942US2010234439A1Therapeutic agentsCHENG LEIFENG·Filed 2007·Application pending·0 cites
- 1042US2010234438A1Therapeutic agentsCHENG LEIFENG·Filed 2007·Application pending·0 cites
- 1142US2009088439A1Diazinane CompoundsCHENG LEIFENG·Filed 2008·Application pending·0 cites
- 1240US7799804B2Therapeutic agentsASTRAZENECA AB·Filed 2005·Granted Sep 21, 2010·0 cites·10 claims
- 1340US2009227555A2Novel Pyridine CompoundsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1440US2008306115A1Midazole-4-Carboxamide Derivatives For Use As Cb1 ModulatorsCHENG LEIFENG·Filed 2006·Application pending·0 cites
- 1539US2008319019A1Therapeutic AgentsCHENG LEIFENG·Filed 2005·Application pending·0 cites
- 1639US2008146614A1Therapeutic AgentsCHENG LEIFENG·Filed 2005·Application pending·0 cites
- 1738US5648338AInhibitors and substrates of thrombinTHROMBOSIS RES INST·Filed 1994·Granted Jul 15, 1997·5 cites·29 claims
- 1838US2007093505A12,3-Substituted 5,6-diaryl-pyrazine derivatives as cb1 modulatorsASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 1938US2009023704A1Novel Compounds 737ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2037US2009088441A1Quinoline CompoundsCHENG LEIFENG·Filed 2008·Application pending·0 cites
- 2137US2009156616A1Therapeutic agentsBOSTROM JONAS·Filed 2006·Application pending·0 cites
- 2237US2009005415A11,2-Diarylimidazoles for Use as Cb1 ModulatorsAHLQVIST MATTI·Filed 2006·Application pending·0 cites
- 2336US6387881B1Inhibitors and substrates of thrombinTRIGEN LTD·Filed 1998·Granted May 14, 2002·2 cites·23 claims
- 2436US2006122230A11,5-Diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulatorsASTRAZENECA AB·Filed 2003·Application pending·0 cites
- 2536US2008287517A1Pyrazole Derivatives as Cb1 ModulatorsCHENG LEIFENG·Filed 2006·Application pending·0 cites
- 2636US2008051433A1Pyrrole-3-Carboxamide Derivatives for the Treatment of ObesityBJORSNE MAGNUS·Filed 2005·Application pending·0 cites
- 2735US2009149463A1Therapeutic agentsCHENG LEIFENG·Filed 2005·Application pending·0 cites
- 2821US8415378B2Isoxazol-3(2H)-one analogs as therapeutic agentsBOSTROEM JONAS·Filed 2010·Granted Apr 9, 2013·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Leifeng Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →